SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-002331
Filing Date
2020-01-29
Accepted
2020-01-29 20:04:54
Documents
2
Period of Report
2020-01-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5210
2 EX-24 DOCUMENT attachment1.htm EX-24 4662
  Complete submission text file 0000899243-20-002331.txt   11351
Mailing Address C/O REGULUS THERAPEUTICS INC. 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address
Menzel Garry E (Reporting) CIK: 0001556064 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39200 | Film No.: 20559526

Mailing Address 139 MAIN STREET CAMBRIDGE MA 02142
Business Address 139 MAIN STREET CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Issuer) CIK: 0001701541 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)